Nurexone Biologic Inc (NRX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NRX.VN | SHRX.VN | ARCH.VN | ||
| Company | Nurexone Biologic Inc | Sharp Therapeutics Corp | Arch Biopartners Inc | ||
| Price Information | |||||
| Exchange | TSX Venture | TSX Venture | TSX Venture | ||
| Open | 0.660 | 2.250 | 0.830 | ||
| High | 0.670 | 2.250 | 0.830 | ||
| Low | 0.650 | 2.250 | 0.830 | ||
| Latest | 0.650 | 2.250 | 0.830 | ||
| Change | -0.040 | unch | -0.010 | ||
| % Change | -5.80% | unch | -1.19% | ||
| Volume | 38,485 | 8,100 | 1,440 | ||
| 20-Day Average Volume | 30,654 | 3,065 | 158,444 | ||
| Previous Close | 0.690 | 2.250 | 0.840 | ||
| Industry | TSX Biotechnology | TSX Biotechnology | TSX Biotechnology | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.666 | 3.112 | 0.897 | ||
| 20-Day Raw Stochastic | 28.57% | 26.80% | 33.33% | ||
| 20-Day Relative Strength | 46.87 | 44.11 | 38.47 | ||
| Weighted Alpha | +4.85 | N/A | -59.00 | ||
| Today's Opinion | 80% Sell | N/A | 88% Sell | ||
| Previous Opinion | 48% Sell | N/A | 88% Sell | ||
| Last Month's Opinion | 64% Sell | N/A | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.52% since 02/23/26 | +32.35% since 01/02/26 | -4.60% since 02/23/26 | ||
| Low | 0.650 on 03/02/26 | 1.700 on 01/08/26 | 0.790 on 02/27/26 | ||
| High | 0.690 on 02/27/26 | 2.400 on 01/15/26 | 0.890 on 02/25/26 | ||
| 1-Month | |||||
| %Chg | -7.14% since 02/02/26 | -6.25% since 01/15/26 | -17.82% since 02/02/26 | ||
| Low | 0.630 on 02/12/26 | 2.200 on 02/17/26 | 0.670 on 02/09/26 | ||
| High | 0.700 on 02/03/26 | 2.250 on 02/18/26 | 1.150 on 02/03/26 | ||
| 3-Month | |||||
| %Chg | -7.14% since 12/02/25 | -43.04% since 11/18/25 | -35.16% since 12/02/25 | ||
| Low | 0.610 on 12/12/25 | 1.280 on 01/02/26 | 0.670 on 02/09/26 | ||
| High | 0.700 on 02/03/26 | 3.350 on 12/03/25 | 1.450 on 01/12/26 | ||
| 6-Month | |||||
| %Chg | -20.73% since 09/02/25 | +350.00% since 06/25/25 | -50.89% since 09/02/25 | ||
| Low | 0.610 on 12/12/25 | 0.230 on 10/03/25 | 0.670 on 02/09/26 | ||
| High | 1.140 on 09/16/25 | 5.000 on 11/06/25 | 1.720 on 09/04/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 62,570 | 67,670 | 56,224 | ||
| Shares Outstanding, K | 90,681 | 30,076 | 66,933 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -5,043,000 | -3,260,640 | -1,552,744 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -1,465,000 | -1,085,473 | -269,758 | ||
| 60-Month Beta | 0.71 | N/A | 2.05 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 11/26/25 | -0.04 on 11/26/25 | -0.02 | ||
| Latest Earnings Date | 04/08/26 | N/A | N/A | ||
| Most Recent Dividend | N/A | N/A | 0.200 on 09/13/00 | ||
| Next Ex-Dividends Date | N/A | N/A | 09/13/00 | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | N/A | N/A | ||